Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis

Table 1 Clinicopathological features of liver tissues

Clinicopathological parameters		No. of cases (%)
		HCC	CCA
Total		213	203
Gender	Male	185 (86.9)	112 (55.2)
	Female	28 (13.1)	91 (44.8)
Age of diagnosis	< 50	106 (49.8)	49 (24.1)
	≥ 50	107 (50.2)	154 (75.9)
Mean (range)		50 (19-85)	57 (41-78)
Region	Country	82 (38.5)	112 (55.2)
	Urban	131 (61.5)	91 (44.8)
AFP	< 400	134 (62.9)	-
	≥ 400	79 (37.1)	-
HBsAg	+	166 (77.9)	140 (69.0)
	-	47 (22.1)	63 (31.0)
Tumor size	< 5 cm	92 (43.2)	98 (48.3)
	≥ 5 cm	121 (56.8)	105 (51.7)
Stage	pT1	9 (4.2)	14 (6.9)
	pT2	73 (34.3)	105 (51.7)
	pT3	24 (11.3)	21 (10.3)
	pT4	107 (50.2)	63 (31.0)
Nodal status	N0	190 (89.2)	182 (89.7)
	N1	23 (10.8)	21 (10.3)
Metastasis	M0	188 (88.2)	182 (89.7)
	M1	25 (11.8)	21 (10.3)
UICC stage at diagnosis	I	16 (7.5)	14 (6.9)
	II	106 (49.8)	98 (48.3)
	III	28 (13.6)	21 (10.3)
	IV	63 (29.6)	70 (34.5)
Tumor grading	I	79 (37.1)	75 (36.9)
	II	76 (35.7)	72 (35.7)
	III	58 (27.2)	56 (27.6)

Data in parenthesis are percentages except the line of “mean”. AFP: α-fetoprotein; CCA: Cholangiocellular carcinoma; HBsAg: Hepatitis B surface antigen; HCC: Hepatocellular carcinoma; UICC: Union for International Cancer Control.